208 related articles for article (PubMed ID: 34049238)
1. Interaction of LL-37 human cathelicidin peptide with a model microbial-like lipid membrane.
Majewska M; Zamlynny V; Pieta IS; Nowakowski R; Pieta P
Bioelectrochemistry; 2021 Oct; 141():107842. PubMed ID: 34049238
[TBL] [Abstract][Full Text] [Related]
2. Membrane Core-Specific Antimicrobial Action of Cathelicidin LL-37 Peptide Switches Between Pore and Nanofibre Formation.
Shahmiri M; Enciso M; Adda CG; Smith BJ; Perugini MA; Mechler A
Sci Rep; 2016 Nov; 6():38184. PubMed ID: 27901075
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of lipid bilayer disruption by the human antimicrobial peptide, LL-37.
Henzler Wildman KA; Lee DK; Ramamoorthy A
Biochemistry; 2003 Jun; 42(21):6545-58. PubMed ID: 12767238
[TBL] [Abstract][Full Text] [Related]
4. The C-Terminal VPRTES Tail of LL-37 Influences the Mode of Attachment to a Lipid Bilayer and Antimicrobial Activity.
de Miguel Catalina A; Forbrig E; Kozuch J; Nehls C; Paulowski L; Gutsmann T; Hildebrandt P; Mroginski MA
Biochemistry; 2019 May; 58(19):2447-2462. PubMed ID: 31016971
[TBL] [Abstract][Full Text] [Related]
5. Electrochemical screening of anti-microbial peptide LL-37 interaction with phospholipids.
Neville F; Gidalevitz D; Kale G; Nelson A
Bioelectrochemistry; 2007 May; 70(2):205-13. PubMed ID: 16949887
[TBL] [Abstract][Full Text] [Related]
6. Interactions of GF-17 derived from LL-37 antimicrobial peptide with bacterial membranes: a molecular dynamics simulation study.
Aghazadeh H; Ganjali Koli M; Ranjbar R; Pooshang Bagheri K
J Comput Aided Mol Des; 2020 Dec; 34(12):1261-1273. PubMed ID: 33009624
[TBL] [Abstract][Full Text] [Related]
7. Structure and orientation of the mammalian antibacterial peptide cecropin P1 within phospholipid membranes.
Gazit E; Miller IR; Biggin PC; Sansom MS; Shai Y
J Mol Biol; 1996 May; 258(5):860-70. PubMed ID: 8637016
[TBL] [Abstract][Full Text] [Related]
8. Perturbation of the hydrophobic core of lipid bilayers by the human antimicrobial peptide LL-37.
Henzler-Wildman KA; Martinez GV; Brown MF; Ramamoorthy A
Biochemistry; 2004 Jul; 43(26):8459-69. PubMed ID: 15222757
[TBL] [Abstract][Full Text] [Related]
9. Primate cathelicidin orthologues display different structures and membrane interactions.
Morgera F; Vaccari L; Antcheva N; Scaini D; Pacor S; Tossi A
Biochem J; 2009 Feb; 417(3):727-35. PubMed ID: 18922132
[TBL] [Abstract][Full Text] [Related]
10. Structure and organization of the human antimicrobial peptide LL-37 in phospholipid membranes: relevance to the molecular basis for its non-cell-selective activity.
Oren Z; Lerman JC; Gudmundsson GH; Agerberth B; Shai Y
Biochem J; 1999 Aug; 341 ( Pt 3)(Pt 3):501-13. PubMed ID: 10417311
[TBL] [Abstract][Full Text] [Related]
11. How lipids influence the mode of action of membrane-active peptides.
Sevcsik E; Pabst G; Jilek A; Lohner K
Biochim Biophys Acta; 2007 Oct; 1768(10):2586-95. PubMed ID: 17662236
[TBL] [Abstract][Full Text] [Related]
12. Phospholipid-driven differences determine the action of the synthetic antimicrobial peptide OP-145 on Gram-positive bacterial and mammalian membrane model systems.
Malanovic N; Leber R; Schmuck M; Kriechbaum M; Cordfunke RA; Drijfhout JW; de Breij A; Nibbering PH; Kolb D; Lohner K
Biochim Biophys Acta; 2015 Oct; 1848(10 Pt A):2437-47. PubMed ID: 26210299
[TBL] [Abstract][Full Text] [Related]
13. Structural Plasticity of LL-37 Indicates Elaborate Functional Adaptation Mechanisms to Bacterial Target Structures.
Zeth K; Sancho-Vaello E
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34068993
[TBL] [Abstract][Full Text] [Related]
14. High-quality 3D structures shine light on antibacterial, anti-biofilm and antiviral activities of human cathelicidin LL-37 and its fragments.
Wang G; Mishra B; Epand RF; Epand RM
Biochim Biophys Acta; 2014 Sep; 1838(9):2160-72. PubMed ID: 24463069
[TBL] [Abstract][Full Text] [Related]
15. Molecular Dynamics Simulations of Human Antimicrobial Peptide LL-37 in Model POPC and POPG Lipid Bilayers.
Zhao L; Cao Z; Bian Y; Hu G; Wang J; Zhou Y
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29652823
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial Peptide Structure and Mechanism of Action: A Focus on the Role of Membrane Structure.
Lee TH; Hall KN; Aguilar MI
Curr Top Med Chem; 2016; 16(1):25-39. PubMed ID: 26139112
[TBL] [Abstract][Full Text] [Related]
17. LL-37-derived short antimicrobial peptide KR-12-a5 and its d-amino acid substituted analogs with cell selectivity, anti-biofilm activity, synergistic effect with conventional antibiotics, and anti-inflammatory activity.
Kim EY; Rajasekaran G; Shin SY
Eur J Med Chem; 2017 Aug; 136():428-441. PubMed ID: 28525841
[TBL] [Abstract][Full Text] [Related]
18. Molecular insights into the interactions of GF-17 with the gram-negative and gram-positive bacterial lipid bilayers.
Jahangiri S; Jafari M; Arjomand M; Mehrnejad F
J Cell Biochem; 2018 Nov; 119(11):9205-9216. PubMed ID: 30076752
[TBL] [Abstract][Full Text] [Related]
19. A Spectroscopic Study of the Aggregation State of the Human Antimicrobial Peptide LL-37 in Bacterial versus Host Cell Model Membranes.
Bonucci A; Caldaroni E; Balducci E; Pogni R
Biochemistry; 2015 Nov; 54(45):6760-8. PubMed ID: 26502164
[TBL] [Abstract][Full Text] [Related]
20. Membrane insertion and bilayer perturbation by antimicrobial peptide CM15.
Pistolesi S; Pogni R; Feix JB
Biophys J; 2007 Sep; 93(5):1651-60. PubMed ID: 17496013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
